Total: £ 56.28
Published Date: 2025-09-17 | Pages: 98 | Tables: 94 | Pharma & Healthcare
The global Pharmaceutical Amino Acids market size was US$ 1386 million in 2024 and is forecast to a readjusted size of US$ 1640 million by 2031 with a CAGR of 2.5% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Pharmaceutical Amino Acids market competitiveness, regional economic performance, and supply chain configurations.
Amino acids (AAs) are a group of organic molecules in which each is comprised of a basic amino group (-NH2), an acidic carboxyl group (-COOH), and an organic R group (or side chain) that is unique to each amino acid. Amino acids are building blocks of proteins, as well as the intermediates in metabolism. The amino and the carboxyl groups of amino acids react to form a covalent amide linkage, called a peptide bond. This feature of amino acids allows them to polymerize to form proteins as well as peptides, which generally have shorter amino acid chain length. Amino acids can be classified into three groups: essential amino acids, non-essential amino acids and conditional amino acids. Amino acids are commonly used as supplements in cell culture media and in metabolism research.
The main manufacturers of Pharmaceutical Amino Acids are Ajinomoto, Evonik and Meihua Holding Group, etc. The top five manufacturers account for about 70% of the share. The USMCA is the largest market with about 35% share, followed by Europe and Asia with more than 25% share. Glycine is the largest segment, with a roughly 30% share. Active Pharmaceuticals Ingredients (APIs) is the largest application with a share of around 60%.
The global Pharmaceutical Amino Acids market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Ajinomoto
Evonik
Kyowa Hakko
AMINO
Meihua Holding Group
Tianjin Tianyao
Jingjing
Wuxi Jinghai
Jiahe Biotech
Hubei Bafeng
Grand Hoyo
Yichang Sanxia Proudin
Shine Star
By Type: (Dominant Segment vs High-Margin Innovation)
Glycine
L-Threonine
L-Alanine
L-Leucine
L-Cysteine
L-Arginine
L-Valine
L-Isoleucine
By Application: (Core Demand Driver vs Emerging Opportunity)
Active Pharmaceuticals Ingredients (APIs)
Pharmaceutical Intermediates
Cell Culture Media Ingredients
Pharmaceutical Excipients
Medical Food
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Ajinomoto in Europe)
- Emerging Product Trends: Glycine adoption vs. L-Threonine premiumization
- Demand-Side Dynamics: Active Pharmaceuticals Ingredients (APIs) growth in China vs. Pharmaceutical Intermediates potential in Europe
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pharmaceutical Amino Acids market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., L-Threonine in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmaceutical Intermediates in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Glycine dominance in Europe vs. L-Threonine demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Pharmaceutical Amino Acids Product Scope
1.2 Pharmaceutical Amino Acids by Type
1.2.1 Global Pharmaceutical Amino Acids Sales by Type (2020 & 2024 & 2031)
1.2.2 Glycine
1.2.3 L-Threonine
1.2.4 L-Alanine
1.2.5 L-Leucine
1.2.6 L-Cysteine
1.2.7 L-Arginine
1.2.8 L-Valine
1.2.9 L-Isoleucine
1.3 Pharmaceutical Amino Acids by Application
1.3.1 Global Pharmaceutical Amino Acids Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Active Pharmaceuticals Ingredients (APIs)
1.3.3 Pharmaceutical Intermediates
1.3.4 Cell Culture Media Ingredients
1.3.5 Pharmaceutical Excipients
1.3.6 Medical Food
1.4 Global Pharmaceutical Amino Acids Market Estimates and Forecasts (2020-2031)
1.4.1 Global Pharmaceutical Amino Acids Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Pharmaceutical Amino Acids Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Pharmaceutical Amino Acids Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Pharmaceutical Amino Acids Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Pharmaceutical Amino Acids Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Pharmaceutical Amino Acids Sales Market Share by Region (2020-2025)
2.2.2 Global Pharmaceutical Amino Acids Revenue Market Share by Region (2020-2025)
2.3 Global Pharmaceutical Amino Acids Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Pharmaceutical Amino Acids Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Pharmaceutical Amino Acids Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 Europe Pharmaceutical Amino Acids Market Size and Prospective (2020-2031)
2.4.2 China Pharmaceutical Amino Acids Market Size and Prospective (2020-2031)
2.4.3 Japan Pharmaceutical Amino Acids Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Pharmaceutical Amino Acids Historic Market Review by Type (2020-2025)
3.1.1 Global Pharmaceutical Amino Acids Sales by Type (2020-2025)
3.1.2 Global Pharmaceutical Amino Acids Revenue by Type (2020-2025)
3.1.3 Global Pharmaceutical Amino Acids Price by Type (2020-2025)
3.2 Global Pharmaceutical Amino Acids Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Pharmaceutical Amino Acids Sales Forecast by Type (2026-2031)
3.2.2 Global Pharmaceutical Amino Acids Revenue Forecast by Type (2026-2031)
3.2.3 Global Pharmaceutical Amino Acids Price Forecast by Type (2026-2031)
3.3 Different Types Pharmaceutical Amino Acids Representative Players
4 Global Market Size by Application
4.1 Global Pharmaceutical Amino Acids Historic Market Review by Application (2020-2025)
4.1.1 Global Pharmaceutical Amino Acids Sales by Application (2020-2025)
4.1.2 Global Pharmaceutical Amino Acids Revenue by Application (2020-2025)
4.1.3 Global Pharmaceutical Amino Acids Price by Application (2020-2025)
4.2 Global Pharmaceutical Amino Acids Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Pharmaceutical Amino Acids Sales Forecast by Application (2026-2031)
4.2.2 Global Pharmaceutical Amino Acids Revenue Forecast by Application (2026-2031)
4.2.3 Global Pharmaceutical Amino Acids Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Pharmaceutical Amino Acids Application
5 Competition Landscape by Players
5.1 Global Pharmaceutical Amino Acids Sales by Players (2020-2025)
5.2 Global Top Pharmaceutical Amino Acids Players by Revenue (2020-2025)
5.3 Global Pharmaceutical Amino Acids Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Amino Acids as of 2024)
5.4 Global Pharmaceutical Amino Acids Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Pharmaceutical Amino Acids, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Pharmaceutical Amino Acids, Product Type & Application
5.7 Global Key Manufacturers of Pharmaceutical Amino Acids, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 Europe Market: Players, Segments, Downstream and Major Customers
6.1.1 Europe Pharmaceutical Amino Acids Sales by Company
6.1.1.1 Europe Pharmaceutical Amino Acids Sales by Company (2020-2025)
6.1.1.2 Europe Pharmaceutical Amino Acids Revenue by Company (2020-2025)
6.1.2 Europe Pharmaceutical Amino Acids Sales Breakdown by Type (2020-2025)
6.1.3 Europe Pharmaceutical Amino Acids Sales Breakdown by Application (2020-2025)
6.1.4 Europe Pharmaceutical Amino Acids Major Customer
6.1.5 Europe Market Trend and Opportunities
6.2 China Market: Players, Segments, Downstream and Major Customers
6.2.1 China Pharmaceutical Amino Acids Sales by Company
6.2.1.1 China Pharmaceutical Amino Acids Sales by Company (2020-2025)
6.2.1.2 China Pharmaceutical Amino Acids Revenue by Company (2020-2025)
6.2.2 China Pharmaceutical Amino Acids Sales Breakdown by Type (2020-2025)
6.2.3 China Pharmaceutical Amino Acids Sales Breakdown by Application (2020-2025)
6.2.4 China Pharmaceutical Amino Acids Major Customer
6.2.5 China Market Trend and Opportunities
6.3 Japan Market: Players, Segments, Downstream and Major Customers
6.3.1 Japan Pharmaceutical Amino Acids Sales by Company
6.3.1.1 Japan Pharmaceutical Amino Acids Sales by Company (2020-2025)
6.3.1.2 Japan Pharmaceutical Amino Acids Revenue by Company (2020-2025)
6.3.2 Japan Pharmaceutical Amino Acids Sales Breakdown by Type (2020-2025)
6.3.3 Japan Pharmaceutical Amino Acids Sales Breakdown by Application (2020-2025)
6.3.4 Japan Pharmaceutical Amino Acids Major Customer
6.3.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Ajinomoto
7.1.1 Ajinomoto Company Information
7.1.2 Ajinomoto Business Overview
7.1.3 Ajinomoto Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Ajinomoto Pharmaceutical Amino Acids Products Offered
7.1.5 Ajinomoto Recent Development
7.2 Evonik
7.2.1 Evonik Company Information
7.2.2 Evonik Business Overview
7.2.3 Evonik Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Evonik Pharmaceutical Amino Acids Products Offered
7.2.5 Evonik Recent Development
7.3 Kyowa Hakko
7.3.1 Kyowa Hakko Company Information
7.3.2 Kyowa Hakko Business Overview
7.3.3 Kyowa Hakko Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Kyowa Hakko Pharmaceutical Amino Acids Products Offered
7.3.5 Kyowa Hakko Recent Development
7.4 AMINO
7.4.1 AMINO Company Information
7.4.2 AMINO Business Overview
7.4.3 AMINO Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.4.4 AMINO Pharmaceutical Amino Acids Products Offered
7.4.5 AMINO Recent Development
7.5 Meihua Holding Group
7.5.1 Meihua Holding Group Company Information
7.5.2 Meihua Holding Group Business Overview
7.5.3 Meihua Holding Group Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Meihua Holding Group Pharmaceutical Amino Acids Products Offered
7.5.5 Meihua Holding Group Recent Development
7.6 Tianjin Tianyao
7.6.1 Tianjin Tianyao Company Information
7.6.2 Tianjin Tianyao Business Overview
7.6.3 Tianjin Tianyao Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Tianjin Tianyao Pharmaceutical Amino Acids Products Offered
7.6.5 Tianjin Tianyao Recent Development
7.7 Jingjing
7.7.1 Jingjing Company Information
7.7.2 Jingjing Business Overview
7.7.3 Jingjing Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Jingjing Pharmaceutical Amino Acids Products Offered
7.7.5 Jingjing Recent Development
7.8 Wuxi Jinghai
7.8.1 Wuxi Jinghai Company Information
7.8.2 Wuxi Jinghai Business Overview
7.8.3 Wuxi Jinghai Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Wuxi Jinghai Pharmaceutical Amino Acids Products Offered
7.8.5 Wuxi Jinghai Recent Development
7.9 Jiahe Biotech
7.9.1 Jiahe Biotech Company Information
7.9.2 Jiahe Biotech Business Overview
7.9.3 Jiahe Biotech Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Jiahe Biotech Pharmaceutical Amino Acids Products Offered
7.9.5 Jiahe Biotech Recent Development
7.10 Hubei Bafeng
7.10.1 Hubei Bafeng Company Information
7.10.2 Hubei Bafeng Business Overview
7.10.3 Hubei Bafeng Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Hubei Bafeng Pharmaceutical Amino Acids Products Offered
7.10.5 Hubei Bafeng Recent Development
7.11 Grand Hoyo
7.11.1 Grand Hoyo Company Information
7.11.2 Grand Hoyo Business Overview
7.11.3 Grand Hoyo Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Grand Hoyo Pharmaceutical Amino Acids Products Offered
7.11.5 Grand Hoyo Recent Development
7.12 Yichang Sanxia Proudin
7.12.1 Yichang Sanxia Proudin Company Information
7.12.2 Yichang Sanxia Proudin Business Overview
7.12.3 Yichang Sanxia Proudin Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Yichang Sanxia Proudin Pharmaceutical Amino Acids Products Offered
7.12.5 Yichang Sanxia Proudin Recent Development
7.13 Shine Star
7.13.1 Shine Star Company Information
7.13.2 Shine Star Business Overview
7.13.3 Shine Star Pharmaceutical Amino Acids Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Shine Star Pharmaceutical Amino Acids Products Offered
7.13.5 Shine Star Recent Development
8 Pharmaceutical Amino Acids Manufacturing Cost Analysis
8.1 Pharmaceutical Amino Acids Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Pharmaceutical Amino Acids
8.4 Pharmaceutical Amino Acids Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Pharmaceutical Amino Acids Distributors List
9.3 Pharmaceutical Amino Acids Customers
10 Pharmaceutical Amino Acids Market Dynamics
10.1 Pharmaceutical Amino Acids Industry Trends
10.2 Pharmaceutical Amino Acids Market Drivers
10.3 Pharmaceutical Amino Acids Market Challenges
10.4 Pharmaceutical Amino Acids Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Amino Acids Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Pharmaceutical Amino Acids Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Pharmaceutical Amino Acids Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Pharmaceutical Amino Acids Sales (Tons) by Region (2020-2025)
Table 5. Global Pharmaceutical Amino Acids Sales Market Share by Region (2020-2025)
Table 6. Global Pharmaceutical Amino Acids Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Pharmaceutical Amino Acids Revenue Share by Region (2020-2025)
Table 8. Global Pharmaceutical Amino Acids Sales (Tons) Forecast by Region (2026-2031)
Table 9. Global Pharmaceutical Amino Acids Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Pharmaceutical Amino Acids Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Pharmaceutical Amino Acids Revenue Share Forecast by Region (2026-2031)
Table 12. Global Pharmaceutical Amino Acids Sales by Type (Tons) & (2020-2025)
Table 13. Global Pharmaceutical Amino Acids Sales Share by Type (2020-2025)
Table 14. Global Pharmaceutical Amino Acids Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Pharmaceutical Amino Acids Price by Type (US$/Ton) & (2020-2025)
Table 16. Global Pharmaceutical Amino Acids Sales by Type (Tons) & (2026-2031)
Table 17. Global Pharmaceutical Amino Acids Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Pharmaceutical Amino Acids Price by Type (US$/Ton) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Pharmaceutical Amino Acids Sales by Application (Tons) & (2020-2025)
Table 21. Global Pharmaceutical Amino Acids Sales Share by Application (2020-2025)
Table 22. Global Pharmaceutical Amino Acids Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Pharmaceutical Amino Acids Price by Application (US$/Ton) & (2020-2025)
Table 24. Global Pharmaceutical Amino Acids Sales by Application (Tons) & (2026-2031)
Table 25. Global Pharmaceutical Amino Acids Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Pharmaceutical Amino Acids Price by Application (US$/Ton) & (2026-2031)
Table 27. New Sources of Growth in Pharmaceutical Amino Acids Application
Table 28. Global Pharmaceutical Amino Acids Sales by Company (Tons) & (2020-2025)
Table 29. Global Pharmaceutical Amino Acids Sales Share by Company (2020-2025)
Table 30. Global Pharmaceutical Amino Acids Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Pharmaceutical Amino Acids Revenue Share by Company (2020-2025)
Table 32. Global Pharmaceutical Amino Acids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Amino Acids as of 2024)
Table 33. Global Market Pharmaceutical Amino Acids Average Price by Company (US$/Ton) & (2020-2025)
Table 34. Global Key Manufacturers of Pharmaceutical Amino Acids, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Pharmaceutical Amino Acids, Product Type & Application
Table 36. Global Key Manufacturers of Pharmaceutical Amino Acids, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. Europe Pharmaceutical Amino Acids Sales by Company (2020-2025) & (Tons)
Table 39. Europe Pharmaceutical Amino Acids Sales Market Share by Company (2020-2025)
Table 40. Europe Pharmaceutical Amino Acids Revenue by Company (2020-2025) & (US$ Million)
Table 41. Europe Pharmaceutical Amino Acids Revenue Market Share by Company (2020-2025)
Table 42. Europe Pharmaceutical Amino Acids Sales by Type (2020-2025) & (Tons)
Table 43. Europe Pharmaceutical Amino Acids Sales Market Share by Type (2020-2025)
Table 44. Europe Pharmaceutical Amino Acids Sales by Application (2020-2025) & (Tons)
Table 45. Europe Pharmaceutical Amino Acids Sales Market Share by Application (2020-2025)
Table 46. China Pharmaceutical Amino Acids Sales by Company (2020-2025) & (Tons)
Table 47. China Pharmaceutical Amino Acids Sales Market Share by Company (2020-2025)
Table 48. China Pharmaceutical Amino Acids Revenue by Company (2020-2025) & (US$ Million)
Table 49. China Pharmaceutical Amino Acids Revenue Market Share by Company (2020-2025)
Table 50. China Pharmaceutical Amino Acids Sales by Type (2020-2025) & (Tons)
Table 51. China Pharmaceutical Amino Acids Sales Market Share by Type (2020-2025)
Table 52. China Pharmaceutical Amino Acids Sales by Application (2020-2025) & (Tons)
Table 53. China Pharmaceutical Amino Acids Sales Market Share by Application (2020-2025)
Table 54. Japan Pharmaceutical Amino Acids Sales by Company (2020-2025) & (Tons)
Table 55. Japan Pharmaceutical Amino Acids Sales Market Share by Company (2020-2025)
Table 56. Japan Pharmaceutical Amino Acids Revenue by Company (2020-2025) & (US$ Million)
Table 57. Japan Pharmaceutical Amino Acids Revenue Market Share by Company (2020-2025)
Table 58. Japan Pharmaceutical Amino Acids Sales by Type (2020-2025) & (Tons)
Table 59. Japan Pharmaceutical Amino Acids Sales Market Share by Type (2020-2025)
Table 60. Japan Pharmaceutical Amino Acids Sales by Application (2020-2025) & (Tons)
Table 61. Japan Pharmaceutical Amino Acids Sales Market Share by Application (2020-2025)
Table 62. Ajinomoto Company Information
Table 63. Ajinomoto Description and Business Overview
Table 64. Ajinomoto Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 65. Ajinomoto Pharmaceutical Amino Acids Product
Table 66. Ajinomoto Recent Development
Table 67. Evonik Company Information
Table 68. Evonik Description and Business Overview
Table 69. Evonik Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 70. Evonik Pharmaceutical Amino Acids Product
Table 71. Evonik Recent Development
Table 72. Kyowa Hakko Company Information
Table 73. Kyowa Hakko Description and Business Overview
Table 74. Kyowa Hakko Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Kyowa Hakko Pharmaceutical Amino Acids Product
Table 76. Kyowa Hakko Recent Development
Table 77. AMINO Company Information
Table 78. AMINO Description and Business Overview
Table 79. AMINO Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 80. AMINO Pharmaceutical Amino Acids Product
Table 81. AMINO Recent Development
Table 82. Meihua Holding Group Company Information
Table 83. Meihua Holding Group Description and Business Overview
Table 84. Meihua Holding Group Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 85. Meihua Holding Group Pharmaceutical Amino Acids Product
Table 86. Meihua Holding Group Recent Development
Table 87. Tianjin Tianyao Company Information
Table 88. Tianjin Tianyao Description and Business Overview
Table 89. Tianjin Tianyao Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 90. Tianjin Tianyao Pharmaceutical Amino Acids Product
Table 91. Tianjin Tianyao Recent Development
Table 92. Jingjing Company Information
Table 93. Jingjing Description and Business Overview
Table 94. Jingjing Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 95. Jingjing Pharmaceutical Amino Acids Product
Table 96. Jingjing Recent Development
Table 97. Wuxi Jinghai Company Information
Table 98. Wuxi Jinghai Description and Business Overview
Table 99. Wuxi Jinghai Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 100. Wuxi Jinghai Pharmaceutical Amino Acids Product
Table 101. Wuxi Jinghai Recent Development
Table 102. Jiahe Biotech Company Information
Table 103. Jiahe Biotech Description and Business Overview
Table 104. Jiahe Biotech Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 105. Jiahe Biotech Pharmaceutical Amino Acids Product
Table 106. Jiahe Biotech Recent Development
Table 107. Hubei Bafeng Company Information
Table 108. Hubei Bafeng Description and Business Overview
Table 109. Hubei Bafeng Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 110. Hubei Bafeng Pharmaceutical Amino Acids Product
Table 111. Hubei Bafeng Recent Development
Table 112. Grand Hoyo Company Information
Table 113. Grand Hoyo Description and Business Overview
Table 114. Grand Hoyo Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 115. Grand Hoyo Pharmaceutical Amino Acids Product
Table 116. Grand Hoyo Recent Development
Table 117. Yichang Sanxia Proudin Company Information
Table 118. Yichang Sanxia Proudin Description and Business Overview
Table 119. Yichang Sanxia Proudin Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 120. Yichang Sanxia Proudin Pharmaceutical Amino Acids Product
Table 121. Yichang Sanxia Proudin Recent Development
Table 122. Shine Star Company Information
Table 123. Shine Star Description and Business Overview
Table 124. Shine Star Pharmaceutical Amino Acids Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 125. Shine Star Pharmaceutical Amino Acids Product
Table 126. Shine Star Recent Development
Table 127. Production Base and Market Concentration Rate of Raw Material
Table 128. Key Suppliers of Raw Materials
Table 129. Pharmaceutical Amino Acids Distributors List
Table 130. Pharmaceutical Amino Acids Customers List
Table 131. Pharmaceutical Amino Acids Market Trends
Table 132. Pharmaceutical Amino Acids Market Drivers
Table 133. Pharmaceutical Amino Acids Market Challenges
Table 134. Pharmaceutical Amino Acids Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Amino Acids Product Picture
Figure 2. Global Pharmaceutical Amino Acids Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Pharmaceutical Amino Acids Sales Market Share by Type in 2024 & 2031
Figure 4. Glycine Product Picture
Figure 5. L-Threonine Product Picture
Figure 6. L-Alanine Product Picture
Figure 7. L-Leucine Product Picture
Figure 8. L-Cysteine Product Picture
Figure 9. L-Arginine Product Picture
Figure 10. L-Valine Product Picture
Figure 11. L-Isoleucine Product Picture
Figure 12. Global Pharmaceutical Amino Acids Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 13. Global Pharmaceutical Amino Acids Sales Market Share by Application in 2024 & 2031
Figure 14. Active Pharmaceuticals Ingredients (APIs) Examples
Figure 15. Pharmaceutical Intermediates Examples
Figure 16. Cell Culture Media Ingredients Examples
Figure 17. Pharmaceutical Excipients Examples
Figure 18. Medical Food Examples
Figure 19. Global Pharmaceutical Amino Acids Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Pharmaceutical Amino Acids Sales Growth Rate (2020-2031) & (US$ Million)
Figure 21. Global Pharmaceutical Amino Acids Sales (Tons) Growth Rate (2020-2031)
Figure 22. Global Pharmaceutical Amino Acids Price Trends Growth Rate (2020-2031) & (US$/Ton)
Figure 23. Pharmaceutical Amino Acids Report Years Considered
Figure 24. Global Market Pharmaceutical Amino Acids Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 25. Global Pharmaceutical Amino Acids Revenue Market Share by Region: 2020 VS 2024
Figure 26. Europe Pharmaceutical Amino Acids Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Europe Pharmaceutical Amino Acids Sales (Tons) Growth Rate (2020-2031)
Figure 28. China Pharmaceutical Amino Acids Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. China Pharmaceutical Amino Acids Sales (Tons) Growth Rate (2020-2031)
Figure 30. Japan Pharmaceutical Amino Acids Revenue (US$ Million) Growth Rate (2020-2031)
Figure 31. Japan Pharmaceutical Amino Acids Sales (Tons) Growth Rate (2020-2031)
Figure 32. Global Pharmaceutical Amino Acids Revenue Share by Type (2020-2025)
Figure 33. Global Pharmaceutical Amino Acids Sales Share by Type (2026-2031)
Figure 34. Global Pharmaceutical Amino Acids Revenue Share by Type (2026-2031)
Figure 35. Global Pharmaceutical Amino Acids Revenue Share by Application (2020-2025)
Figure 36. Global Pharmaceutical Amino Acids Revenue Growth Rate by Application in 2020 & 2024
Figure 37. Global Pharmaceutical Amino Acids Sales Share by Application (2026-2031)
Figure 38. Global Pharmaceutical Amino Acids Revenue Share by Application (2026-2031)
Figure 39. Global Pharmaceutical Amino Acids Sales Share by Company (2024)
Figure 40. Global Pharmaceutical Amino Acids Revenue Share by Company (2024)
Figure 41. Global 5 Largest Pharmaceutical Amino Acids Players Market Share by Revenue in Pharmaceutical Amino Acids: 2020 & 2024
Figure 42. Pharmaceutical Amino Acids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 43. Manufacturing Cost Structure of Pharmaceutical Amino Acids
Figure 44. Manufacturing Process Analysis of Pharmaceutical Amino Acids
Figure 45. Pharmaceutical Amino Acids Industrial Chain
Figure 46. Channels of Distribution (Direct Vs Distribution)
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed